Understanding the Maintenance Dose of Wegovy: A Comprehensive Guide

Last reviewed: June 26, 2026

Last updated: June 26, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide maintenance dosing differs significantly from the initial titration phase, where patients gradually increase their injectable dose every four weeks. Most people reach a stable maintenance dose between 1.0 and 2.4 milligrams weekly, depending on individual metabolic response and tolerability. Understanding how maintenance dosing works helps you plan your long-term treatment strategy and financial investment in weight management.

What Is Semaglutide Maintenance Dosing?

Maintenance dosing refers to the consistent weekly injection amount your body tolerates and responds to after the titration phase concludes. During the first 16 weeks of treatment, most patients start at 0.25 mg weekly and increase by 0.25 mg every four weeks until reaching their therapeutic target or experiencing side effects that warrant staying at a lower level. Once you reach a dose where weight loss continues steadily and gastrointestinal symptoms remain manageable, you've found your maintenance level.

The maintenance phase typically lasts for months or years, depending on your weight loss goals and how long you choose to continue treatment. Clinical trials show that patients who stay on their maintenance dose continue experiencing gradual weight reduction for 52 weeks or longer, with many seeing cumulative weight loss of 15–22% of their starting body weight. Your maintenance dose is not fixed forever—your prescriber may adjust it if your response changes or if side effects emerge over time.

Common Maintenance Dose Ranges and Expected Results

Most patients find their optimal maintenance dose somewhere between 0.5 mg and 2.4 mg per week, though individual variation is substantial. A dose of 1.0 mg weekly represents a common middle ground where appetite suppression becomes noticeable without overwhelming nausea or vomiting in most people. Higher doses (1.5–2.4 mg) typically produce stronger weight loss signals but may increase the likelihood of persistent side effects like delayed stomach emptying or appetite loss that affects nutrition intake.

Research published in clinical endocrinology journals indicates that maintenance doses of 2.0–2.4 mg weekly produce the most significant weight reductions, often resulting in 20% or greater total body weight loss over 12 months in compliant patients. However, lower maintenance doses (0.5–1.0 mg) still provide meaningful metabolic benefits, including improved fasting glucose, better insulin sensitivity, and modest appetite reduction. Your ideal maintenance dose balances maximum therapeutic benefit against your personal tolerance for side effects and your lifestyle demands.

How Maintenance Differs From Titration and Induction Phases

The titration phase, which spans the first month to four months of treatment, involves stepping your dose up incrementally to build tolerance and identify your therapeutic window. During titration, you may experience stronger side effects as your body adjusts to semaglutide's appetite-suppressing signals. The maintenance phase begins once you stop increasing your dose and settle into a consistent weekly injection amount that produces desired weight loss without intolerable nausea, constipation, or other adverse effects.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Wegovy or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

PlexusDx Compounded Semaglutide: Cost-Transparent Maintenance Support

PlexusDx delivers compounded semaglutide injections from licensed 503A compounding pharmacies to all 50 states, at $189/mo month-to-month, or from $149/mo on the 6-month plan regardless of your maintenance dose level. This flat-rate pricing model means that if your prescriber increases you from 0.5 mg to 2.0 mg weekly as your maintenance target, your monthly cost stays fixed—your dose may need to go up, but your price won't. This transparency eliminates the financial uncertainty many patients face when titratingthrough multiple dose increases with traditional retail pharmacies.

PlexusDx compounded semaglutide is HSA and FSA eligible, reducing your true out-of-pocket cost if you carry a qualified health account. No insurance is required, and there are no membership fees or surprise billing tiers. After your first month of treatment, you can add the Precision Peptide Genetic Test ($298) to gain insight into how your specific genetic variants influence semaglutide metabolism and optimal dose range, empowering both you and your prescriber to refine your maintenance strategy with data-driven confidence.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

How long does it take to reach a semaglutide maintenance dose?

Most patients reach a stable maintenance dose within 16–20 weeks, increasing by 0.25 mg every four weeks. However, some people prefer a slower titration (increasing every 2–3 weeks instead) to minimize side effects, which extends the timeline to 5–6 months. Once your prescriber identifies a dose that balances weight loss and tolerability, you typically remain at that maintenance level for several months or longer.

Will I need to increase my maintenance dose over time?

Some patients experience dose tolerance—where their initial maintenance dose becomes less effective after 6–12 months of consistent use. Clinical evidence suggests that modest dose increases (0.25–0.5 mg jumps) can restore efficacy if plateau occurs. However, many people maintain steady weight loss on the same dose indefinitely, particularly if they combine semaglutide with consistent nutrition and exercise habits.

Does PlexusDx charge more if my maintenance dose increases?

No. PlexusDx compounded semaglutide injections maintain flat monthly pricing at $189/mo (or $149/mo on the 6-month plan) and up across all dose levels—whether you're taking 0.25 mg or 2.4 mg weekly. This pricing model ensures that dose adjustments during your maintenance phase never trigger unexpected cost increases.

What happens if my maintenance dose causes persistent nausea or other side effects?

If side effects become intolerable, your prescriber can reduce your maintenance dose by 0.25–0.5 mg and reassess tolerability. Some patients find that a slightly lower dose still provides meaningful weight loss while dramatically improving quality of life. In other cases, switching to oral semaglutide or exploring alternative medications like compounded tirzepatide may offer a better benefit-to-side-effect ratio.

How does PlexusDx's genetic test help with finding my optimal maintenance dose?

No — the Precision Peptide Genetic Test does not predict your response to Wegovy or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Ro Wegovy
• Mochi Wegovy
• Noom Wegovy
• Hims Wegovy

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.